Palace Capital PLC
LSE:PCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Palace Capital PLC
LSE:PCA
|
UK |
|
E
|
Euroapi SAS
OTC:EAPIF
|
FR |
|
Guillemot Corporation SA
F:GUL
|
FR |
|
SAR Auto Products Ltd
BSE:538992
|
IN |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Fastly Inc
NASDAQ:FSLY
|
US |
|
W
|
Wolters Kluwer NV
XHAM:WOSB
|
NL |
|
T
|
Thungela Resources Ltd
JSE:TGA
|
ZA |
|
Oncopeptides AB
STO:ONCO
|
SE |
|
BRC Asia Ltd
SGX:BEC
|
SG |
|
American Tower Corp
NYSE:AMT
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCA's stock price target?
Not Available
PCA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Palace Capital PLC?
Projected CAGR
-8%
Over the last 12 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 1 year is -8%.
What is the Gross Profit forecast for Palace Capital PLC?
Projected CAGR
40%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 3 years is 40%.
What is the Pre-Tax Income forecast for Palace Capital PLC?
Projected CAGR
141%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 141%.
What is the Net Income forecast for Palace Capital PLC?
Projected CAGR
141%
The compound annual growth rate for Net Income over the next 2 years is 141%.